Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Eckstein

Showing results (171-180 of 263) with videos related to

Pageof 27
Sort By:
The FEBS Journal|May 31, 2023
CD24 targeting with NK-CAR immunotherapy in testis, prostate, renal and (luminal-type) bladder cancer and identification of direct CD24 interaction partnersChristian Söhngen, David J Thomas, Margaretha A Skowron, et al.
Cancer Management and Research|August 27, 2021
The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder CancerDanijel Sikic, Helge Taubert, Johannes Breyer, et al.
Scientific Reports|June 11, 2026
Expression of progranulin (GP88) protein appears as an independent prognostic factor for clinical progression in high-risk prostate cancer patientsRenata Dubrovska, Markus Eckstein, Rudolf Jung, et al.
Clinical Genitourinary Cancer|March 18, 2020
Multicentric Analytical and Inter-observer Comparability of Four Clinically Developed Programmed Death-ligand 1 Immunohistochemistry Assays in Advanced Clear-cell Renal Cell CarcinomaUlrich Sommer, Markus Eckstein, Johannes Ammann, et al.
Acta Oto-Laryngologica|October 28, 2020
Influence of p16 status on indication and outcome of salvage neck dissection in oropharyngeal cancerSarina Katrin Mueller, Konstantinos Mantsopoulos, Sabine Semrau, et al.
Journal of Clinical Medicine|April 8, 2020
FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical CystectomyDanijel Sikic, Markus Eckstein, Ralph M Wirtz, et al.
Cancers|March 29, 2023
The Chorioallantoic Membrane Xenograft Assay as a Reliable Model for Investigating the Biology of Breast CancerRaphela A Ranjan, Julienne K Muenzner, Philipp Kunze, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 9, 2022
CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancerSiyuan Zeng, Bin Lan, Xiaofan Ren, et al.
Laryngo- Rhino- Otologie|July 23, 2021
[Therapies for synchronous malignomas - the importance of interdisciplinary oncology]Sarina Müller, Marlen Haderlein, Maximilian Traxdorf, et al.
Cancers|June 2, 2021
Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer PatientsVeronika Weyerer, Pamela L Strissel, Reiner Strick, et al.
Pageof 27

Showing results (171-180 of 263) with videos related to

Sort By:
Pageof 27
The FEBS Journal|May 31, 2023
CD24 targeting with NK-CAR immunotherapy in testis, prostate, renal and (luminal-type) bladder cancer and identification of direct CD24 interaction partnersChristian Söhngen, David J Thomas, Margaretha A Skowron, et al.
Cancer Management and Research|August 27, 2021
The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder CancerDanijel Sikic, Helge Taubert, Johannes Breyer, et al.
Scientific Reports|June 11, 2026
Expression of progranulin (GP88) protein appears as an independent prognostic factor for clinical progression in high-risk prostate cancer patientsRenata Dubrovska, Markus Eckstein, Rudolf Jung, et al.
Clinical Genitourinary Cancer|March 18, 2020
Multicentric Analytical and Inter-observer Comparability of Four Clinically Developed Programmed Death-ligand 1 Immunohistochemistry Assays in Advanced Clear-cell Renal Cell CarcinomaUlrich Sommer, Markus Eckstein, Johannes Ammann, et al.
Acta Oto-Laryngologica|October 28, 2020
Influence of p16 status on indication and outcome of salvage neck dissection in oropharyngeal cancerSarina Katrin Mueller, Konstantinos Mantsopoulos, Sabine Semrau, et al.
Journal of Clinical Medicine|April 8, 2020
FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical CystectomyDanijel Sikic, Markus Eckstein, Ralph M Wirtz, et al.
Cancers|March 29, 2023
The Chorioallantoic Membrane Xenograft Assay as a Reliable Model for Investigating the Biology of Breast CancerRaphela A Ranjan, Julienne K Muenzner, Philipp Kunze, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 9, 2022
CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancerSiyuan Zeng, Bin Lan, Xiaofan Ren, et al.
Laryngo- Rhino- Otologie|July 23, 2021
[Therapies for synchronous malignomas - the importance of interdisciplinary oncology]Sarina Müller, Marlen Haderlein, Maximilian Traxdorf, et al.
Cancers|June 2, 2021
Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer PatientsVeronika Weyerer, Pamela L Strissel, Reiner Strick, et al.
Pageof 27